id	sid	tid	token	lemma	pos
dhrp-26	1	1	2021	2021	NUM
dhrp-26	1	2	,	,	PUNCT
dhrp-26	1	3	vol	vol	NOUN
dhrp-26	1	4	.	.	NOUN
dhrp-26	1	5	1	1	NUM
dhrp-26	1	6	(	(	PUNCT
dhrp-26	1	7	s4	s4	PROPN
dhrp-26	1	8	)	)	PUNCT
dhrp-26	1	9	13	13	NUM
dhrp-26	1	10	-	-	SYM
dhrp-26	1	11	14	14	NUM
dhrp-26	1	12	https://doi.org/10.47488/dhrp.v1is4.26	https://doi.org/10.47488/dhrp.v1is4.26	ADJ
dhrp-26	1	13	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-26	1	14	13	13	NUM
dhrp-26	1	15	©	©	PROPN
dhrp-26	1	16	dhr	dhr	PROPN
dhrp-26	1	17	health	health	PROPN
dhrp-26	1	18	institute	institute	PROPN
dhrp-26	1	19	for	for	ADP
dhrp-26	1	20	research	research	NOUN
dhrp-26	1	21	and	and	CCONJ
dhrp-26	1	22	development	development	NOUN
dhrp-26	1	23	editorial	editorial	NOUN
dhrp-26	1	24	messenger	messenger	NOUN
dhrp-26	1	25	rna	rna	NOUN
dhrp-26	1	26	vaccines	vaccine	NOUN
dhrp-26	1	27	are	be	AUX
dhrp-26	1	28	safe	safe	ADJ
dhrp-26	1	29	&	&	CCONJ
dhrp-26	1	30	effective	effective	ADJ
dhrp-26	1	31	and	and	CCONJ
dhrp-26	1	32	do	do	AUX
dhrp-26	1	33	not	not	PART
dhrp-26	1	34	modify	modify	VERB
dhrp-26	1	35	host	host	NOUN
dhrp-26	1	36	dna	dna	NOUN
dhrp-26	1	37	despite	despite	SCONJ
dhrp-26	1	38	the	the	DET
dhrp-26	1	39	fact	fact	NOUN
dhrp-26	1	40	that	that	SCONJ
dhrp-26	1	41	over	over	ADP
dhrp-26	1	42	5.3	5.3	NUM
dhrp-26	1	43	billion	billion	NUM
dhrp-26	1	44	doses	dose	NOUN
dhrp-26	1	45	of	of	ADP
dhrp-26	1	46	covid-19	covid-19	PROPN
dhrp-26	1	47	vaccines	vaccine	NOUN
dhrp-26	1	48	have	have	AUX
dhrp-26	1	49	been	be	AUX
dhrp-26	1	50	administered	administer	VERB
dhrp-26	1	51	globally	globally	ADV
dhrp-26	1	52	,	,	PUNCT
dhrp-26	1	53	there	there	PRON
dhrp-26	1	54	still	still	ADV
dhrp-26	1	55	exists	exist	VERB
dhrp-26	1	56	measurable	measurable	ADJ
dhrp-26	1	57	hesitancy	hesitancy	NOUN
dhrp-26	1	58	in	in	ADP
dhrp-26	1	59	a	a	DET
dhrp-26	1	60	select	select	ADJ
dhrp-26	1	61	cohort	cohort	NOUN
dhrp-26	1	62	of	of	ADP
dhrp-26	1	63	the	the	DET
dhrp-26	1	64	population	population	NOUN
dhrp-26	1	65	to	to	PART
dhrp-26	1	66	get	get	VERB
dhrp-26	1	67	vaccinated	vaccinate	VERB
dhrp-26	1	68	.	.	PUNCT
dhrp-26	2	1	this	this	DET
dhrp-26	2	2	reluctance	reluctance	NOUN
dhrp-26	2	3	seems	seem	VERB
dhrp-26	2	4	to	to	PART
dhrp-26	2	5	be	be	AUX
dhrp-26	2	6	more	more	ADV
dhrp-26	2	7	evident	evident	ADJ
dhrp-26	2	8	towards	towards	ADP
dhrp-26	2	9	messenger	messenger	NOUN
dhrp-26	2	10	rna	rna	PROPN
dhrp-26	2	11	(	(	PUNCT
dhrp-26	2	12	mrna	mrna	PROPN
dhrp-26	2	13	)	)	PUNCT
dhrp-26	2	14	vaccines	vaccine	NOUN
dhrp-26	2	15	which	which	PRON
dhrp-26	2	16	is	be	AUX
dhrp-26	2	17	attributed	attribute	VERB
dhrp-26	2	18	largely	largely	ADV
dhrp-26	2	19	to	to	ADP
dhrp-26	2	20	misinformation	misinformation	NOUN
dhrp-26	2	21	about	about	ADP
dhrp-26	2	22	their	their	PRON
dhrp-26	2	23	safety	safety	NOUN
dhrp-26	2	24	and	and	CCONJ
dhrp-26	2	25	efficacy	efficacy	NOUN
dhrp-26	2	26	and	and	CCONJ
dhrp-26	2	27	the	the	DET
dhrp-26	2	28	unfounded	unfounded	ADJ
dhrp-26	2	29	fear	fear	NOUN
dhrp-26	2	30	that	that	SCONJ
dhrp-26	2	31	they	they	PRON
dhrp-26	2	32	may	may	AUX
dhrp-26	2	33	integrate	integrate	VERB
dhrp-26	2	34	into	into	ADP
dhrp-26	2	35	host	host	NOUN
dhrp-26	2	36	dna	dna	NOUN
dhrp-26	2	37	thus	thus	ADV
dhrp-26	2	38	modifying	modify	VERB
dhrp-26	2	39	it	it	PRON
dhrp-26	2	40	permanently	permanently	ADV
dhrp-26	2	41	.	.	PUNCT
dhrp-26	3	1	in	in	ADP
dhrp-26	3	2	this	this	DET
dhrp-26	3	3	editorial	editorial	NOUN
dhrp-26	3	4	,	,	PUNCT
dhrp-26	3	5	we	we	PRON
dhrp-26	3	6	plan	plan	VERB
dhrp-26	3	7	to	to	PART
dhrp-26	3	8	provide	provide	VERB
dhrp-26	3	9	scientific	scientific	ADJ
dhrp-26	3	10	evidence	evidence	NOUN
dhrp-26	3	11	to	to	PART
dhrp-26	3	12	repudiate	repudiate	VERB
dhrp-26	3	13	these	these	DET
dhrp-26	3	14	misconceptions	misconception	NOUN
dhrp-26	3	15	and	and	CCONJ
dhrp-26	3	16	to	to	PART
dhrp-26	3	17	alleviate	alleviate	VERB
dhrp-26	3	18	concerns	concern	NOUN
dhrp-26	3	19	related	relate	VERB
dhrp-26	3	20	to	to	ADP
dhrp-26	3	21	covid-19	covid-19	PROPN
dhrp-26	3	22	mrna	mrna	NOUN
dhrp-26	3	23	vaccines	vaccine	NOUN
dhrp-26	3	24	.	.	PUNCT
dhrp-26	4	1	on	on	ADP
dhrp-26	4	2	december	december	PROPN
dhrp-26	4	3	11	11	NUM
dhrp-26	4	4	,	,	PUNCT
dhrp-26	4	5	2020	2020	NUM
dhrp-26	4	6	,	,	PUNCT
dhrp-26	4	7	us	us	PROPN
dhrp-26	4	8	food	food	PROPN
dhrp-26	4	9	&	&	CCONJ
dhrp-26	4	10	drug	drug	PROPN
dhrp-26	4	11	administration	administration	PROPN
dhrp-26	4	12	(	(	PUNCT
dhrp-26	4	13	fda	fda	PROPN
dhrp-26	4	14	)	)	PUNCT
dhrp-26	4	15	issued	issue	VERB
dhrp-26	4	16	its	its	PRON
dhrp-26	4	17	first	first	ADJ
dhrp-26	4	18	emergency	emergency	NOUN
dhrp-26	4	19	use	use	NOUN
dhrp-26	4	20	authorization	authorization	NOUN
dhrp-26	4	21	(	(	PUNCT
dhrp-26	4	22	eua	eua	PROPN
dhrp-26	4	23	)	)	PUNCT
dhrp-26	4	24	for	for	ADP
dhrp-26	4	25	pfizer	pfizer	NOUN
dhrp-26	4	26	/	/	SYM
dhrp-26	4	27	biontech	biontech	NOUN
dhrp-26	4	28	covid-19	covid-19	PROPN
dhrp-26	4	29	vaccine	vaccine	NOUN
dhrp-26	4	30	for	for	ADP
dhrp-26	4	31	the	the	DET
dhrp-26	4	32	prevention	prevention	NOUN
dhrp-26	4	33	of	of	ADP
dhrp-26	4	34	covid19	covid19	NOUN
dhrp-26	4	35	caused	cause	VERB
dhrp-26	4	36	by	by	ADP
dhrp-26	4	37	sars	sar	NOUN
dhrp-26	4	38	-	-	PUNCT
dhrp-26	4	39	cov-2	cov-2	NOUN
dhrp-26	4	40	in	in	ADP
dhrp-26	4	41	individuals	individual	NOUN
dhrp-26	4	42	16	16	NUM
dhrp-26	4	43	years	year	NOUN
dhrp-26	4	44	of	of	ADP
dhrp-26	4	45	age	age	NOUN
dhrp-26	4	46	and	and	CCONJ
dhrp-26	4	47	over	over	ADP
dhrp-26	4	48	(	(	PUNCT
dhrp-26	4	49	1	1	NUM
dhrp-26	4	50	)	)	PUNCT
dhrp-26	4	51	.	.	PUNCT
dhrp-26	5	1	the	the	DET
dhrp-26	5	2	pfizer	pfizer	NOUN
dhrp-26	5	3	/	/	SYM
dhrp-26	5	4	biontech	biontech	NOUN
dhrp-26	5	5	vaccine	vaccine	NOUN
dhrp-26	5	6	is	be	AUX
dhrp-26	5	7	a	a	DET
dhrp-26	5	8	nucleoside	nucleoside	ADV
dhrp-26	5	9	-	-	PUNCT
dhrp-26	5	10	modified	modify	VERB
dhrp-26	5	11	mrna	mrna	NOUN
dhrp-26	5	12	encoding	encoding	NOUN
dhrp-26	5	13	for	for	ADP
dhrp-26	5	14	the	the	DET
dhrp-26	5	15	viral	viral	ADJ
dhrp-26	5	16	spike	spike	ADJ
dhrp-26	5	17	glycoprotein	glycoprotein	NOUN
dhrp-26	5	18	of	of	ADP
dhrp-26	5	19	sars	sar	NOUN
dhrp-26	5	20	-	-	PUNCT
dhrp-26	5	21	cov-2	cov-2	NOUN
dhrp-26	5	22	formulated	formulate	VERB
dhrp-26	5	23	in	in	ADP
dhrp-26	5	24	lipid	lipid	NOUN
dhrp-26	5	25	particle	particle	NOUN
dhrp-26	5	26	(	(	PUNCT
dhrp-26	5	27	1	1	NUM
dhrp-26	5	28	)	)	PUNCT
dhrp-26	5	29	.	.	PUNCT
dhrp-26	6	1	on	on	ADP
dhrp-26	6	2	may	may	PROPN
dhrp-26	6	3	10	10	NUM
dhrp-26	6	4	,	,	PUNCT
dhrp-26	6	5	2021	2021	NUM
dhrp-26	6	6	,	,	PUNCT
dhrp-26	6	7	fda	fda	PROPN
dhrp-26	6	8	issued	issue	VERB
dhrp-26	6	9	another	another	DET
dhrp-26	6	10	eua	eua	PROPN
dhrp-26	6	11	approving	approve	VERB
dhrp-26	6	12	the	the	DET
dhrp-26	6	13	use	use	NOUN
dhrp-26	6	14	of	of	ADP
dhrp-26	6	15	pfizer	pfizer	NOUN
dhrp-26	6	16	/	/	SYM
dhrp-26	6	17	biontech	biontech	NOUN
dhrp-26	6	18	vaccine	vaccine	NOUN
dhrp-26	6	19	for	for	ADP
dhrp-26	6	20	prevention	prevention	NOUN
dhrp-26	6	21	of	of	ADP
dhrp-26	6	22	covid-19	covid-19	PROPN
dhrp-26	6	23	in	in	ADP
dhrp-26	6	24	individuals	individual	NOUN
dhrp-26	6	25	12	12	NUM
dhrp-26	6	26	-	-	SYM
dhrp-26	6	27	15	15	NUM
dhrp-26	6	28	years	year	NOUN
dhrp-26	6	29	of	of	ADP
dhrp-26	6	30	age	age	NOUN
dhrp-26	6	31	(	(	PUNCT
dhrp-26	6	32	2	2	NUM
dhrp-26	6	33	)	)	PUNCT
dhrp-26	6	34	.	.	PUNCT
dhrp-26	7	1	given	give	VERB
dhrp-26	7	2	the	the	DET
dhrp-26	7	3	high	high	ADJ
dhrp-26	7	4	risk	risk	NOUN
dhrp-26	7	5	of	of	ADP
dhrp-26	7	6	infection	infection	NOUN
dhrp-26	7	7	with	with	ADP
dhrp-26	7	8	the	the	DET
dhrp-26	7	9	delta	delta	NOUN
dhrp-26	7	10	variant	variant	NOUN
dhrp-26	7	11	of	of	ADP
dhrp-26	7	12	vaccinated	vaccinated	ADJ
dhrp-26	7	13	individuals	individual	NOUN
dhrp-26	7	14	with	with	ADP
dhrp-26	7	15	immunosuppressed	immunosuppressed	ADJ
dhrp-26	7	16	status	status	NOUN
dhrp-26	7	17	,	,	PUNCT
dhrp-26	7	18	on	on	ADP
dhrp-26	7	19	august	august	PROPN
dhrp-26	7	20	12	12	NUM
dhrp-26	7	21	,	,	PUNCT
dhrp-26	7	22	2021	2021	NUM
dhrp-26	7	23	,	,	PUNCT
dhrp-26	7	24	fda	fda	PROPN
dhrp-26	7	25	modified	modify	VERB
dhrp-26	7	26	its	its	PRON
dhrp-26	7	27	eua	eua	NOUN
dhrp-26	7	28	allowing	allow	VERB
dhrp-26	7	29	pfizer	pfizer	NOUN
dhrp-26	7	30	/	/	SYM
dhrp-26	7	31	biontech	biontech	NOUN
dhrp-26	7	32	vaccine	vaccine	NOUN
dhrp-26	7	33	to	to	PART
dhrp-26	7	34	be	be	AUX
dhrp-26	7	35	administered	administer	VERB
dhrp-26	7	36	as	as	ADP
dhrp-26	7	37	a	a	DET
dhrp-26	7	38	third	third	ADJ
dhrp-26	7	39	dose	dose	NOUN
dhrp-26	7	40	to	to	ADP
dhrp-26	7	41	this	this	DET
dhrp-26	7	42	select	select	ADJ
dhrp-26	7	43	cohort	cohort	NOUN
dhrp-26	7	44	of	of	ADP
dhrp-26	7	45	patients	patient	NOUN
dhrp-26	7	46	.	.	PUNCT
dhrp-26	8	1	with	with	ADP
dhrp-26	8	2	the	the	DET
dhrp-26	8	3	availability	availability	NOUN
dhrp-26	8	4	of	of	ADP
dhrp-26	8	5	additional	additional	ADJ
dhrp-26	8	6	safety	safety	NOUN
dhrp-26	8	7	and	and	CCONJ
dhrp-26	8	8	efficacy	efficacy	NOUN
dhrp-26	8	9	data	datum	NOUN
dhrp-26	8	10	from	from	ADP
dhrp-26	8	11	millions	million	NOUN
dhrp-26	8	12	of	of	ADP
dhrp-26	8	13	people	people	NOUN
dhrp-26	8	14	who	who	PRON
dhrp-26	8	15	have	have	AUX
dhrp-26	8	16	been	be	AUX
dhrp-26	8	17	vaccinated	vaccinate	VERB
dhrp-26	8	18	supplemented	supplement	VERB
dhrp-26	8	19	by	by	ADP
dhrp-26	8	20	that	that	PRON
dhrp-26	8	21	obtained	obtain	VERB
dhrp-26	8	22	from	from	ADP
dhrp-26	8	23	double	double	ADJ
dhrp-26	8	24	-	-	PUNCT
dhrp-26	8	25	blinded	blind	VERB
dhrp-26	8	26	placebo	placebo	NOUN
dhrp-26	8	27	-	-	PUNCT
dhrp-26	8	28	controlled	control	VERB
dhrp-26	8	29	clinical	clinical	ADJ
dhrp-26	8	30	trials	trial	NOUN
dhrp-26	8	31	,	,	PUNCT
dhrp-26	8	32	pfizer	pfizer	NOUN
dhrp-26	8	33	submitted	submit	VERB
dhrp-26	8	34	a	a	DET
dhrp-26	8	35	biologics	biologic	NOUN
dhrp-26	8	36	license	license	NOUN
dhrp-26	8	37	application	application	NOUN
dhrp-26	8	38	(	(	PUNCT
dhrp-26	8	39	bla	bla	NOUN
dhrp-26	8	40	)	)	PUNCT
dhrp-26	8	41	with	with	ADP
dhrp-26	8	42	fda	fda	PROPN
dhrp-26	8	43	requesting	request	VERB
dhrp-26	8	44	full	full	ADJ
dhrp-26	8	45	approval	approval	NOUN
dhrp-26	8	46	of	of	ADP
dhrp-26	8	47	the	the	DET
dhrp-26	8	48	pfizer	pfizer	NOUN
dhrp-26	8	49	/	/	SYM
dhrp-26	8	50	biontech	biontech	NOUN
dhrp-26	8	51	vaccine	vaccine	NOUN
dhrp-26	8	52	for	for	ADP
dhrp-26	8	53	use	use	NOUN
dhrp-26	8	54	in	in	ADP
dhrp-26	8	55	individuals	individual	NOUN
dhrp-26	8	56	12	12	NUM
dhrp-26	8	57	years	year	NOUN
dhrp-26	8	58	of	of	ADP
dhrp-26	8	59	age	age	NOUN
dhrp-26	8	60	and	and	CCONJ
dhrp-26	8	61	older	old	ADJ
dhrp-26	8	62	.	.	PUNCT
dhrp-26	9	1	after	after	ADP
dhrp-26	9	2	careful	careful	ADJ
dhrp-26	9	3	review	review	NOUN
dhrp-26	9	4	,	,	PUNCT
dhrp-26	9	5	fda	fda	PROPN
dhrp-26	9	6	approved	approve	VERB
dhrp-26	9	7	pfizer	pfizer	NOUN
dhrp-26	9	8	’s	’s	PART
dhrp-26	9	9	bla	bla	NOUN
dhrp-26	9	10	on	on	ADP
dhrp-26	9	11	august	august	PROPN
dhrp-26	9	12	23	23	NUM
dhrp-26	9	13	,	,	PUNCT
dhrp-26	9	14	2021	2021	NUM
dhrp-26	9	15	,	,	PUNCT
dhrp-26	9	16	making	make	VERB
dhrp-26	9	17	it	it	PRON
dhrp-26	9	18	the	the	DET
dhrp-26	9	19	first	first	ADJ
dhrp-26	9	20	and	and	CCONJ
dhrp-26	9	21	only	only	ADJ
dhrp-26	9	22	vaccine	vaccine	NOUN
dhrp-26	9	23	for	for	ADP
dhrp-26	9	24	prevention	prevention	NOUN
dhrp-26	9	25	of	of	ADP
dhrp-26	9	26	infection	infection	NOUN
dhrp-26	9	27	with	with	ADP
dhrp-26	9	28	sars	sar	NOUN
dhrp-26	9	29	-	-	PUNCT
dhrp-26	9	30	cov-2	cov-2	PART
dhrp-26	9	31	(	(	PUNCT
dhrp-26	9	32	3	3	NUM
dhrp-26	9	33	)	)	PUNCT
dhrp-26	9	34	.	.	PUNCT
dhrp-26	10	1	pfizer	pfizer	NOUN
dhrp-26	10	2	/	/	SYM
dhrp-26	10	3	biontech	biontech	NOUN
dhrp-26	10	4	vaccine	vaccine	NOUN
dhrp-26	10	5	is	be	AUX
dhrp-26	10	6	now	now	ADV
dhrp-26	10	7	marketed	market	VERB
dhrp-26	10	8	under	under	ADP
dhrp-26	10	9	the	the	DET
dhrp-26	10	10	generic	generic	ADJ
dhrp-26	10	11	name	name	NOUN
dhrp-26	10	12	of	of	ADP
dhrp-26	10	13	comirnaty	comirnaty	NOUN
dhrp-26	10	14	.	.	PUNCT
dhrp-26	11	1	subsequently	subsequently	ADV
dhrp-26	11	2	,	,	PUNCT
dhrp-26	11	3	on	on	ADP
dhrp-26	11	4	december	december	PROPN
dhrp-26	11	5	18	18	NUM
dhrp-26	11	6	,	,	PUNCT
dhrp-26	11	7	2020	2020	NUM
dhrp-26	11	8	,	,	PUNCT
dhrp-26	11	9	fda	fda	PROPN
dhrp-26	11	10	issued	issue	VERB
dhrp-26	11	11	another	another	DET
dhrp-26	11	12	eua	eua	PROPN
dhrp-26	11	13	for	for	ADP
dhrp-26	11	14	moderna	moderna	PROPN
dhrp-26	11	15	covid-19	covid-19	PROPN
dhrp-26	11	16	vaccine	vaccine	NOUN
dhrp-26	11	17	for	for	ADP
dhrp-26	11	18	the	the	DET
dhrp-26	11	19	prevention	prevention	NOUN
dhrp-26	11	20	of	of	ADP
dhrp-26	11	21	covid-19	covid-19	PROPN
dhrp-26	11	22	caused	cause	VERB
dhrp-26	11	23	by	by	ADP
dhrp-26	11	24	sarscov-2	sarscov-2	PROPN
dhrp-26	11	25	in	in	ADP
dhrp-26	11	26	individuals	individual	NOUN
dhrp-26	11	27	18	18	NUM
dhrp-26	11	28	years	year	NOUN
dhrp-26	11	29	of	of	ADP
dhrp-26	11	30	age	age	NOUN
dhrp-26	11	31	and	and	CCONJ
dhrp-26	11	32	over	over	ADP
dhrp-26	11	33	(	(	PUNCT
dhrp-26	11	34	4	4	NUM
dhrp-26	11	35	)	)	PUNCT
dhrp-26	11	36	.	.	PUNCT
dhrp-26	12	1	the	the	DET
dhrp-26	12	2	formulation	formulation	NOUN
dhrp-26	12	3	of	of	ADP
dhrp-26	12	4	moderna	moderna	PROPN
dhrp-26	12	5	’s	’s	PART
dhrp-26	12	6	mrna	mrna	PROPN
dhrp-26	12	7	vaccine	vaccine	NOUN
dhrp-26	12	8	is	be	AUX
dhrp-26	12	9	very	very	ADV
dhrp-26	12	10	similar	similar	ADJ
dhrp-26	12	11	to	to	ADP
dhrp-26	12	12	pfizer	pfizer	NOUN
dhrp-26	12	13	/	/	SYM
dhrp-26	12	14	biontech	biontech	NOUN
dhrp-26	12	15	vaccine	vaccine	NOUN
dhrp-26	12	16	and	and	CCONJ
dhrp-26	12	17	was	be	AUX
dhrp-26	12	18	recommended	recommend	VERB
dhrp-26	12	19	at	at	ADP
dhrp-26	12	20	a	a	DET
dhrp-26	12	21	dosing	dose	VERB
dhrp-26	12	22	regimen	regiman	NOUN
dhrp-26	12	23	of	of	ADP
dhrp-26	12	24	two	two	NUM
dhrp-26	12	25	doses	dose	NOUN
dhrp-26	12	26	administered	administer	VERB
dhrp-26	12	27	one	one	NUM
dhrp-26	12	28	month	month	NOUN
dhrp-26	12	29	apart	apart	ADV
dhrp-26	12	30	.	.	PUNCT
dhrp-26	13	1	moderna	moderna	PROPN
dhrp-26	13	2	mrna	mrna	PROPN
dhrp-26	13	3	vaccine	vaccine	NOUN
dhrp-26	13	4	was	be	AUX
dhrp-26	13	5	also	also	ADV
dhrp-26	13	6	approved	approve	VERB
dhrp-26	13	7	by	by	ADP
dhrp-26	13	8	the	the	DET
dhrp-26	13	9	fda	fda	PROPN
dhrp-26	13	10	for	for	ADP
dhrp-26	13	11	a	a	DET
dhrp-26	13	12	third	third	ADJ
dhrp-26	13	13	dose	dose	NOUN
dhrp-26	13	14	in	in	ADP
dhrp-26	13	15	select	select	ADJ
dhrp-26	13	16	vaccinated	vaccinate	VERB
dhrp-26	13	17	immunocompromised	immunocompromise	VERB
dhrp-26	13	18	individuals	individual	NOUN
dhrp-26	13	19	who	who	PRON
dhrp-26	13	20	are	be	AUX
dhrp-26	13	21	at	at	ADP
dhrp-26	13	22	high	high	ADJ
dhrp-26	13	23	risk	risk	NOUN
dhrp-26	13	24	of	of	ADP
dhrp-26	13	25	developing	develop	VERB
dhrp-26	13	26	infection	infection	NOUN
dhrp-26	13	27	with	with	ADP
dhrp-26	13	28	sars	sar	NOUN
dhrp-26	13	29	-	-	PUNCT
dhrp-26	13	30	cov-2	cov-2	NOUN
dhrp-26	13	31	.	.	PUNCT
dhrp-26	14	1	the	the	DET
dhrp-26	14	2	process	process	NOUN
dhrp-26	14	3	outlined	outline	VERB
dhrp-26	14	4	above	above	ADV
dhrp-26	14	5	underscores	underscore	VERB
dhrp-26	14	6	the	the	DET
dhrp-26	14	7	scrupulous	scrupulous	ADJ
dhrp-26	14	8	details	detail	NOUN
dhrp-26	14	9	with	with	ADP
dhrp-26	14	10	which	which	PRON
dhrp-26	14	11	,	,	PUNCT
dhrp-26	14	12	the	the	DET
dhrp-26	14	13	federal	federal	ADJ
dhrp-26	14	14	regulatory	regulatory	ADJ
dhrp-26	14	15	agencies	agency	NOUN
dhrp-26	14	16	review	review	VERB
dhrp-26	14	17	and	and	CCONJ
dhrp-26	14	18	approve	approve	VERB
dhrp-26	14	19	eua	eua	PROPN
dhrp-26	14	20	’s	’s	PART
dhrp-26	14	21	and	and	CCONJ
dhrp-26	14	22	bla	bla	NOUN
dhrp-26	14	23	’s	’s	NOUN
dhrp-26	14	24	.	.	PUNCT
dhrp-26	15	1	this	this	DET
dhrp-26	15	2	process	process	NOUN
dhrp-26	15	3	is	be	AUX
dhrp-26	15	4	stringently	stringently	ADV
dhrp-26	15	5	coordinated	coordinate	VERB
dhrp-26	15	6	by	by	ADP
dhrp-26	15	7	various	various	ADJ
dhrp-26	15	8	independent	independent	ADJ
dhrp-26	15	9	oversight	oversight	NOUN
dhrp-26	15	10	committees	committee	NOUN
dhrp-26	15	11	including	include	VERB
dhrp-26	15	12	but	but	CCONJ
dhrp-26	15	13	not	not	PART
dhrp-26	15	14	limited	limit	VERB
dhrp-26	15	15	to	to	ADP
dhrp-26	15	16	the	the	DET
dhrp-26	15	17	advisory	advisory	ADJ
dhrp-26	15	18	committee	committee	NOUN
dhrp-26	15	19	on	on	ADP
dhrp-26	15	20	immunization	immunization	NOUN
dhrp-26	15	21	practices	practice	NOUN
dhrp-26	15	22	–	–	PUNCT
dhrp-26	15	23	an	an	DET
dhrp-26	15	24	entity	entity	NOUN
dhrp-26	15	25	within	within	ADP
dhrp-26	15	26	the	the	DET
dhrp-26	15	27	us	us	PROPN
dhrp-26	15	28	centers	center	NOUN
dhrp-26	15	29	for	for	ADP
dhrp-26	15	30	disease	disease	NOUN
dhrp-26	15	31	control	control	PROPN
dhrp-26	15	32	&	&	CCONJ
dhrp-26	15	33	prevention	prevention	NOUN
dhrp-26	15	34	that	that	PRON
dhrp-26	15	35	is	be	AUX
dhrp-26	15	36	composed	compose	VERB
dhrp-26	15	37	of	of	ADP
dhrp-26	15	38	experts	expert	NOUN
dhrp-26	15	39	in	in	ADP
dhrp-26	15	40	the	the	DET
dhrp-26	15	41	field	field	NOUN
dhrp-26	15	42	of	of	ADP
dhrp-26	15	43	infectious	infectious	ADJ
dhrp-26	15	44	diseases	disease	NOUN
dhrp-26	15	45	and	and	CCONJ
dhrp-26	15	46	immunology	immunology	NOUN
dhrp-26	15	47	and	and	CCONJ
dhrp-26	15	48	is	be	AUX
dhrp-26	15	49	responsible	responsible	ADJ
dhrp-26	15	50	for	for	ADP
dhrp-26	15	51	providing	provide	VERB
dhrp-26	15	52	guidance	guidance	NOUN
dhrp-26	15	53	for	for	ADP
dhrp-26	15	54	the	the	DET
dhrp-26	15	55	most	most	ADV
dhrp-26	15	56	effective	effective	ADJ
dhrp-26	15	57	control	control	NOUN
dhrp-26	15	58	of	of	ADP
dhrp-26	15	59	diseases	disease	NOUN
dhrp-26	15	60	that	that	PRON
dhrp-26	15	61	can	can	AUX
dhrp-26	15	62	be	be	AUX
dhrp-26	15	63	prevented	prevent	VERB
dhrp-26	15	64	using	use	VERB
dhrp-26	15	65	vaccines	vaccine	NOUN
dhrp-26	15	66	.	.	PUNCT
dhrp-26	16	1	both	both	PRON
dhrp-26	16	2	pfizer	pfizer	NOUN
dhrp-26	16	3	/	/	SYM
dhrp-26	16	4	biontech	biontech	PROPN
dhrp-26	16	5	and	and	CCONJ
dhrp-26	16	6	moderna	moderna	PROPN
dhrp-26	16	7	vaccines	vaccine	NOUN
dhrp-26	16	8	are	be	AUX
dhrp-26	16	9	strands	strand	NOUN
dhrp-26	16	10	of	of	ADP
dhrp-26	16	11	messenger	messenger	NOUN
dhrp-26	16	12	ribonucleic	ribonucleic	ADJ
dhrp-26	16	13	acid	acid	PROPN
dhrp-26	16	14	(	(	PUNCT
dhrp-26	16	15	mrna	mrna	PROPN
dhrp-26	16	16	)	)	PUNCT
dhrp-26	16	17	encapsulated	encapsulate	VERB
dhrp-26	16	18	in	in	ADP
dhrp-26	16	19	lipid	lipid	ADJ
dhrp-26	16	20	nanoparticles	nanoparticle	NOUN
dhrp-26	16	21	.	.	PUNCT
dhrp-26	17	1	the	the	DET
dhrp-26	17	2	mrna	mrna	PROPN
dhrp-26	17	3	encodes	encodes	PROPN
dhrp-26	17	4	for	for	ADP
dhrp-26	17	5	the	the	DET
dhrp-26	17	6	antigenic	antigenic	ADJ
dhrp-26	17	7	glycoproteins	glycoprotein	NOUN
dhrp-26	17	8	of	of	ADP
dhrp-26	17	9	the	the	DET
dhrp-26	17	10	spike	spike	ADJ
dhrp-26	17	11	(	(	PUNCT
dhrp-26	17	12	s	s	NOUN
dhrp-26	17	13	)	)	PUNCT
dhrp-26	17	14	domain	domain	NOUN
dhrp-26	17	15	of	of	ADP
dhrp-26	17	16	sars	sar	NOUN
dhrp-26	17	17	-	-	PUNCT
dhrp-26	17	18	cov-2	cov-2	NOUN
dhrp-26	17	19	with	with	ADP
dhrp-26	17	20	two	two	NUM
dhrp-26	17	21	proline	proline	NOUN
dhrp-26	17	22	substitutions	substitution	NOUN
dhrp-26	17	23	(	(	PUNCT
dhrp-26	17	24	k986p	k986p	PROPN
dhrp-26	17	25	and	and	CCONJ
dhrp-26	17	26	v987p	v987p	PROPN
dhrp-26	17	27	mutations	mutation	NOUN
dhrp-26	17	28	)	)	PUNCT
dhrp-26	17	29	which	which	PRON
dhrp-26	17	30	,	,	PUNCT
dhrp-26	17	31	stabilizes	stabilize	VERB
dhrp-26	17	32	the	the	DET
dhrp-26	17	33	perfusion	perfusion	NOUN
dhrp-26	17	34	conformation	conformation	NOUN
dhrp-26	17	35	of	of	ADP
dhrp-26	17	36	the	the	DET
dhrp-26	17	37	glycoprotein	glycoprotein	NOUN
dhrp-26	17	38	.	.	PUNCT
dhrp-26	18	1	once	once	ADV
dhrp-26	18	2	delivered	deliver	VERB
dhrp-26	18	3	by	by	ADP
dhrp-26	18	4	intramuscular	intramuscular	ADJ
dhrp-26	18	5	administration	administration	NOUN
dhrp-26	18	6	,	,	PUNCT
dhrp-26	18	7	the	the	DET
dhrp-26	18	8	lipid	lipid	NOUN
dhrp-26	18	9	nanoparticles	nanoparticle	NOUN
dhrp-26	18	10	facilitate	facilitate	VERB
dhrp-26	18	11	the	the	DET
dhrp-26	18	12	uptake	uptake	NOUN
dhrp-26	18	13	of	of	ADP
dhrp-26	18	14	the	the	DET
dhrp-26	18	15	mrna	mrna	PROPN
dhrp-26	18	16	vaccine	vaccine	NOUN
dhrp-26	18	17	by	by	ADP
dhrp-26	18	18	the	the	DET
dhrp-26	18	19	host	host	NOUN
dhrp-26	18	20	antigen	antigen	NOUN
dhrp-26	18	21	presenting	present	VERB
dhrp-26	18	22	cells	cell	NOUN
dhrp-26	18	23	(	(	PUNCT
dhrp-26	18	24	such	such	ADJ
dhrp-26	18	25	as	as	ADP
dhrp-26	18	26	dendritic	dendritic	ADJ
dhrp-26	18	27	cells	cell	NOUN
dhrp-26	18	28	or	or	CCONJ
dhrp-26	18	29	macrophages	macrophage	NOUN
dhrp-26	18	30	)	)	PUNCT
dhrp-26	18	31	and	and	CCONJ
dhrp-26	18	32	its	its	PRON
dhrp-26	18	33	entry	entry	NOUN
dhrp-26	18	34	into	into	ADP
dhrp-26	18	35	the	the	DET
dhrp-26	18	36	cytosol	cytosol	NOUN
dhrp-26	18	37	(	(	PUNCT
dhrp-26	18	38	the	the	DET
dhrp-26	18	39	part	part	NOUN
dhrp-26	18	40	of	of	ADP
dhrp-26	18	41	the	the	DET
dhrp-26	18	42	cell	cell	NOUN
dhrp-26	18	43	that	that	PRON
dhrp-26	18	44	is	be	AUX
dhrp-26	18	45	outside	outside	ADP
dhrp-26	18	46	the	the	DET
dhrp-26	18	47	nucleus	nucleus	NOUN
dhrp-26	18	48	which	which	PRON
dhrp-26	18	49	houses	house	VERB
dhrp-26	18	50	the	the	DET
dhrp-26	18	51	dna	dna	NOUN
dhrp-26	18	52	)	)	PUNCT
dhrp-26	19	1	[	[	X
dhrp-26	19	2	figure	figure	NOUN
dhrp-26	19	3	1	1	NUM
dhrp-26	19	4	]	]	PUNCT
dhrp-26	19	5	]	]	PUNCT
dhrp-26	19	6	.	.	PUNCT
dhrp-26	20	1	utilizing	utilize	VERB
dhrp-26	20	2	the	the	DET
dhrp-26	20	3	host	host	NOUN
dhrp-26	20	4	cell	cell	NOUN
dhrp-26	20	5	’s	’s	PART
dhrp-26	20	6	dhrp	dhrp	ADJ
dhrp-26	20	7	,	,	PUNCT
dhrp-26	20	8	2021	2021	NUM
dhrp-26	20	9	,	,	PUNCT
dhrp-26	20	10	vol	vol	NOUN
dhrp-26	20	11	.	.	NOUN
dhrp-26	20	12	1	1	NUM
dhrp-26	20	13	(	(	PUNCT
dhrp-26	20	14	s4	s4	PROPN
dhrp-26	20	15	)	)	PUNCT
dhrp-26	20	16	13	13	NUM
dhrp-26	20	17	-	-	SYM
dhrp-26	20	18	14	14	NUM
dhrp-26	20	19	editorial	editorial	NOUN
dhrp-26	20	20	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-26	20	21	14	14	NUM
dhrp-26	20	22	©	©	PROPN
dhrp-26	20	23	dhr	dhr	PROPN
dhrp-26	20	24	health	health	PROPN
dhrp-26	20	25	institute	institute	PROPN
dhrp-26	20	26	for	for	ADP
dhrp-26	20	27	research	research	NOUN
dhrp-26	20	28	and	and	CCONJ
dhrp-26	20	29	development	development	NOUN
dhrp-26	20	30	ribosomes	ribosome	NOUN
dhrp-26	20	31	(	(	PUNCT
dhrp-26	20	32	organelle	organelle	NOUN
dhrp-26	20	33	that	that	PRON
dhrp-26	20	34	help	help	VERB
dhrp-26	20	35	in	in	ADP
dhrp-26	20	36	protein	protein	NOUN
dhrp-26	20	37	synthesis	synthesis	NOUN
dhrp-26	20	38	)	)	PUNCT
dhrp-26	20	39	,	,	PUNCT
dhrp-26	20	40	the	the	DET
dhrp-26	20	41	mrna	mrna	PROPN
dhrp-26	20	42	vaccine	vaccine	NOUN
dhrp-26	20	43	is	be	AUX
dhrp-26	20	44	translated	translate	VERB
dhrp-26	20	45	into	into	ADP
dhrp-26	20	46	spike	spike	ADJ
dhrp-26	20	47	proteins	protein	NOUN
dhrp-26	20	48	which	which	PRON
dhrp-26	20	49	are	be	AUX
dhrp-26	20	50	presented	present	VERB
dhrp-26	20	51	on	on	ADP
dhrp-26	20	52	the	the	DET
dhrp-26	20	53	cell	cell	NOUN
dhrp-26	20	54	surface	surface	NOUN
dhrp-26	20	55	to	to	PART
dhrp-26	20	56	raise	raise	VERB
dhrp-26	20	57	t	t	PROPN
dhrp-26	20	58	and	and	CCONJ
dhrp-26	20	59	b	b	PROPN
dhrp-26	20	60	cell	cell	NOUN
dhrp-26	20	61	responses	response	NOUN
dhrp-26	20	62	.	.	PUNCT
dhrp-26	21	1	the	the	DET
dhrp-26	21	2	mrna	mrna	PROPN
dhrp-26	21	3	vaccine	vaccine	NOUN
dhrp-26	21	4	in	in	ADP
dhrp-26	21	5	the	the	DET
dhrp-26	21	6	cytosol	cytosol	NOUN
dhrp-26	21	7	is	be	AUX
dhrp-26	21	8	degraded	degrade	VERB
dhrp-26	21	9	by	by	ADP
dhrp-26	21	10	the	the	DET
dhrp-26	21	11	cell	cell	NOUN
dhrp-26	21	12	in	in	ADP
dhrp-26	21	13	a	a	DET
dhrp-26	21	14	few	few	ADJ
dhrp-26	21	15	days	day	NOUN
dhrp-26	21	16	whereas	whereas	SCONJ
dhrp-26	21	17	,	,	PUNCT
dhrp-26	21	18	similar	similar	ADJ
dhrp-26	21	19	to	to	ADP
dhrp-26	21	20	other	other	ADJ
dhrp-26	21	21	proteins	protein	NOUN
dhrp-26	21	22	made	make	VERB
dhrp-26	21	23	by	by	ADP
dhrp-26	21	24	the	the	DET
dhrp-26	21	25	body	body	NOUN
dhrp-26	21	26	,	,	PUNCT
dhrp-26	21	27	the	the	DET
dhrp-26	21	28	spike	spike	ADJ
dhrp-26	21	29	protein	protein	NOUN
dhrp-26	21	30	survives	survive	VERB
dhrp-26	21	31	for	for	ADP
dhrp-26	21	32	a	a	DET
dhrp-26	21	33	few	few	ADJ
dhrp-26	21	34	weeks	week	NOUN
dhrp-26	21	35	and	and	CCONJ
dhrp-26	21	36	is	be	AUX
dhrp-26	21	37	ultimately	ultimately	ADV
dhrp-26	21	38	cleared	clear	VERB
dhrp-26	21	39	from	from	ADP
dhrp-26	21	40	the	the	DET
dhrp-26	21	41	system	system	NOUN
dhrp-26	21	42	.	.	PUNCT
dhrp-26	22	1	figure	figure	VERB
dhrp-26	22	2	1	1	NUM
dhrp-26	22	3	:	:	PUNCT
dhrp-26	22	4	the	the	DET
dhrp-26	22	5	normal	normal	ADJ
dhrp-26	22	6	“	"	PUNCT
dhrp-26	22	7	physiological	physiological	ADJ
dhrp-26	22	8	”	"	PUNCT
dhrp-26	22	9	pathway	pathway	NOUN
dhrp-26	22	10	utilized	utilize	VERB
dhrp-26	22	11	by	by	ADP
dhrp-26	22	12	the	the	DET
dhrp-26	22	13	covid-19	covid-19	PROPN
dhrp-26	22	14	mrna	mrna	PROPN
dhrp-26	22	15	vaccines	vaccine	NOUN
dhrp-26	22	16	to	to	PART
dhrp-26	22	17	produce	produce	VERB
dhrp-26	22	18	spike	spike	ADJ
dhrp-26	22	19	proteins	protein	NOUN
dhrp-26	22	20	that	that	PRON
dhrp-26	22	21	raise	raise	VERB
dhrp-26	22	22	both	both	DET
dhrp-26	22	23	cell	cell	NOUN
dhrp-26	22	24	and	and	CCONJ
dhrp-26	22	25	antibody	antibody	NOUN
dhrp-26	22	26	mediated	mediate	VERB
dhrp-26	22	27	immune	immune	ADJ
dhrp-26	22	28	responses	response	NOUN
dhrp-26	22	29	.	.	PUNCT
dhrp-26	23	1	in	in	ADP
dhrp-26	23	2	conclusion	conclusion	NOUN
dhrp-26	23	3	,	,	PUNCT
dhrp-26	23	4	mrna	mrna	PROPN
dhrp-26	23	5	-	-	PUNCT
dhrp-26	23	6	based	base	VERB
dhrp-26	23	7	vaccines	vaccine	NOUN
dhrp-26	23	8	are	be	AUX
dhrp-26	23	9	safe	safe	ADJ
dhrp-26	23	10	,	,	PUNCT
dhrp-26	23	11	effective	effective	ADJ
dhrp-26	23	12	,	,	PUNCT
dhrp-26	23	13	and	and	CCONJ
dhrp-26	23	14	capable	capable	ADJ
dhrp-26	23	15	of	of	ADP
dhrp-26	23	16	raising	raise	VERB
dhrp-26	23	17	both	both	CCONJ
dhrp-26	23	18	antibodymediated	antibodymediate	VERB
dhrp-26	23	19	and	and	CCONJ
dhrp-26	23	20	cellular	cellular	ADJ
dhrp-26	23	21	immune	immune	ADJ
dhrp-26	23	22	responses	response	NOUN
dhrp-26	23	23	against	against	ADP
dhrp-26	23	24	sars	sar	NOUN
dhrp-26	23	25	-	-	PUNCT
dhrp-26	23	26	cov-2	cov-2	NOUN
dhrp-26	23	27	.	.	PUNCT
dhrp-26	24	1	additionally	additionally	ADV
dhrp-26	24	2	,	,	PUNCT
dhrp-26	24	3	all	all	DET
dhrp-26	24	4	available	available	ADJ
dhrp-26	24	5	scientific	scientific	ADJ
dhrp-26	24	6	data	datum	NOUN
dhrp-26	24	7	provides	provide	VERB
dhrp-26	24	8	unequivocal	unequivocal	ADJ
dhrp-26	24	9	evidence	evidence	NOUN
dhrp-26	24	10	that	that	PRON
dhrp-26	24	11	mrnabased	mrnabase	VERB
dhrp-26	24	12	vaccines	vaccine	NOUN
dhrp-26	24	13	follow	follow	VERB
dhrp-26	24	14	the	the	DET
dhrp-26	24	15	normal	normal	ADJ
dhrp-26	24	16	physiological	physiological	ADJ
dhrp-26	24	17	pathways	pathway	NOUN
dhrp-26	24	18	and	and	CCONJ
dhrp-26	24	19	once	once	SCONJ
dhrp-26	24	20	they	they	PRON
dhrp-26	24	21	enter	enter	VERB
dhrp-26	24	22	,	,	PUNCT
dhrp-26	24	23	they	they	PRON
dhrp-26	24	24	remain	remain	VERB
dhrp-26	24	25	confined	confine	VERB
dhrp-26	24	26	to	to	ADP
dhrp-26	24	27	the	the	DET
dhrp-26	24	28	extra	extra	ADJ
dhrp-26	24	29	-	-	ADJ
dhrp-26	24	30	nuclear	nuclear	ADJ
dhrp-26	24	31	part	part	NOUN
dhrp-26	24	32	of	of	ADP
dhrp-26	24	33	the	the	DET
dhrp-26	24	34	host	host	NOUN
dhrp-26	24	35	cell	cell	NOUN
dhrp-26	24	36	and	and	CCONJ
dhrp-26	24	37	are	be	AUX
dhrp-26	24	38	not	not	PART
dhrp-26	24	39	designed	design	VERB
dhrp-26	24	40	to	to	PART
dhrp-26	24	41	gain	gain	VERB
dhrp-26	24	42	entry	entry	NOUN
dhrp-26	24	43	into	into	ADP
dhrp-26	24	44	the	the	DET
dhrp-26	24	45	nucleus	nucleus	NOUN
dhrp-26	24	46	and	and	CCONJ
dhrp-26	24	47	are	be	AUX
dhrp-26	24	48	therefore	therefore	ADV
dhrp-26	24	49	incapable	incapable	ADJ
dhrp-26	24	50	of	of	ADP
dhrp-26	24	51	modifying	modify	VERB
dhrp-26	24	52	the	the	DET
dhrp-26	24	53	dna	dna	NOUN
dhrp-26	24	54	.	.	PUNCT
dhrp-26	25	1	gaining	gain	VERB
dhrp-26	25	2	public	public	ADJ
dhrp-26	25	3	confidence	confidence	NOUN
dhrp-26	25	4	is	be	AUX
dhrp-26	25	5	paramount	paramount	ADJ
dhrp-26	25	6	in	in	ADP
dhrp-26	25	7	the	the	DET
dhrp-26	25	8	success	success	NOUN
dhrp-26	25	9	of	of	ADP
dhrp-26	25	10	the	the	DET
dhrp-26	25	11	ongoing	ongoing	ADJ
dhrp-26	25	12	vaccination	vaccination	NOUN
dhrp-26	25	13	efforts	effort	NOUN
dhrp-26	25	14	to	to	PART
dhrp-26	25	15	mitigate	mitigate	VERB
dhrp-26	25	16	the	the	DET
dhrp-26	25	17	spread	spread	NOUN
dhrp-26	25	18	of	of	ADP
dhrp-26	25	19	covid-19	covid-19	PROPN
dhrp-26	25	20	.	.	PUNCT
dhrp-26	26	1	therefore	therefore	ADV
dhrp-26	26	2	,	,	PUNCT
dhrp-26	26	3	every	every	DET
dhrp-26	26	4	effort	effort	NOUN
dhrp-26	26	5	must	must	AUX
dhrp-26	26	6	be	be	AUX
dhrp-26	26	7	made	make	VERB
dhrp-26	26	8	to	to	PART
dhrp-26	26	9	discount	discount	VERB
dhrp-26	26	10	the	the	DET
dhrp-26	26	11	misinformation	misinformation	NOUN
dhrp-26	26	12	and	and	CCONJ
dhrp-26	26	13	provide	provide	VERB
dhrp-26	26	14	to	to	ADP
dhrp-26	26	15	the	the	DET
dhrp-26	26	16	community	community	NOUN
dhrp-26	26	17	facts	fact	NOUN
dhrp-26	26	18	that	that	PRON
dhrp-26	26	19	are	be	AUX
dhrp-26	26	20	informed	inform	VERB
dhrp-26	26	21	by	by	ADP
dhrp-26	26	22	strong	strong	ADJ
dhrp-26	26	23	scientific	scientific	ADJ
dhrp-26	26	24	evidence	evidence	NOUN
dhrp-26	26	25	.	.	PUNCT
dhrp-26	27	1	references	reference	NOUN
dhrp-26	27	2	1	1	NUM
dhrp-26	27	3	.	.	PUNCT
dhrp-26	28	1	us	us	PROPN
dhrp-26	28	2	food	food	NOUN
dhrp-26	28	3	and	and	CCONJ
dhrp-26	28	4	drug	drug	PROPN
dhrp-26	28	5	administration	administration	NOUN
dhrp-26	28	6	’s	’s	PART
dhrp-26	28	7	letter	letter	NOUN
dhrp-26	28	8	of	of	ADP
dhrp-26	28	9	emergency	emergency	NOUN
dhrp-26	28	10	use	use	VERB
dhrp-26	28	11	authorization	authorization	NOUN
dhrp-26	28	12	for	for	ADP
dhrp-26	28	13	pfizer	pfizer	NOUN
dhrp-26	28	14	/	/	SYM
dhrp-26	28	15	biontech	biontech	PROPN
dhrp-26	28	16	mrna	mrna	PROPN
dhrp-26	28	17	vaccine	vaccine	NOUN
dhrp-26	28	18	for	for	ADP
dhrp-26	28	19	individuals	individual	NOUN
dhrp-26	28	20	17	17	NUM
dhrp-26	28	21	years	year	NOUN
dhrp-26	28	22	of	of	ADP
dhrp-26	28	23	age	age	NOUN
dhrp-26	28	24	and	and	CCONJ
dhrp-26	28	25	older	old	ADJ
dhrp-26	28	26	.	.	PUNCT
dhrp-26	29	1	december	december	PROPN
dhrp-26	29	2	11	11	NUM
dhrp-26	29	3	,	,	PUNCT
dhrp-26	29	4	2020	2020	NUM
dhrp-26	29	5	,	,	PUNCT
dhrp-26	29	6	https://nps.edu/documents/111291366/124403968/pfizerbiontech+covid19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e966	https://nps.edu/documents/111291366/124403968/pfizerbiontech+covid19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e966	X
dhrp-26	29	7	2	2	NUM
dhrp-26	29	8	-	-	PUNCT
dhrp-26	29	9	956c	956c	NUM
dhrp-26	29	10	-	-	PUNCT
dhrp-26	29	11	aa94	aa94	PROPN
dhrp-26	29	12	-	-	PUNCT
dhrp-26	29	13	8d4b	8d4b	ADV
dhrp-26	29	14	-	-	PUNCT
dhrp-26	29	15	a945a6a10b87?t=1608071313236	a945a6a10b87?t=1608071313236	ADJ
dhrp-26	29	16	2	2	X
dhrp-26	29	17	.	.	X
dhrp-26	29	18	us	us	PROPN
dhrp-26	29	19	food	food	NOUN
dhrp-26	29	20	and	and	CCONJ
dhrp-26	29	21	drug	drug	PROPN
dhrp-26	29	22	administration	administration	NOUN
dhrp-26	29	23	’s	’s	PART
dhrp-26	29	24	letter	letter	NOUN
dhrp-26	29	25	of	of	ADP
dhrp-26	29	26	emergency	emergency	NOUN
dhrp-26	29	27	use	use	VERB
dhrp-26	29	28	authorization	authorization	NOUN
dhrp-26	29	29	for	for	ADP
dhrp-26	29	30	pfizer	pfizer	NOUN
dhrp-26	29	31	/	/	SYM
dhrp-26	29	32	biontech	biontech	PROPN
dhrp-26	29	33	mrna	mrna	PROPN
dhrp-26	29	34	vaccine	vaccine	NOUN
dhrp-26	29	35	for	for	ADP
dhrp-26	29	36	individuals	individual	NOUN
dhrp-26	29	37	12	12	NUM
dhrp-26	29	38	-	-	SYM
dhrp-26	29	39	16	16	NUM
dhrp-26	29	40	years	year	NOUN
dhrp-26	29	41	of	of	ADP
dhrp-26	29	42	age	age	NOUN
dhrp-26	29	43	.	.	PUNCT
dhrp-26	30	1	may	may	AUX
dhrp-26	30	2	10	10	NUM
dhrp-26	30	3	,	,	PUNCT
dhrp-26	30	4	2021	2021	NUM
dhrp-26	30	5	.	.	PUNCT
dhrp-26	31	1	https://www.fda.gov/media/144412/download	https://www.fda.gov/media/144412/download	ADV
dhrp-26	32	1	3	3	X
dhrp-26	32	2	.	.	PUNCT
dhrp-26	32	3	us	us	PROPN
dhrp-26	32	4	food	food	NOUN
dhrp-26	32	5	and	and	CCONJ
dhrp-26	32	6	drug	drug	PROPN
dhrp-26	32	7	administration	administration	NOUN
dhrp-26	32	8	’s	’s	PART
dhrp-26	32	9	letter	letter	NOUN
dhrp-26	32	10	of	of	ADP
dhrp-26	32	11	approval	approval	NOUN
dhrp-26	32	12	of	of	ADP
dhrp-26	32	13	biologics	biologic	NOUN
dhrp-26	32	14	license	license	NOUN
dhrp-26	32	15	application	application	NOUN
dhrp-26	32	16	for	for	ADP
dhrp-26	32	17	pfizer	pfizer	NOUN
dhrp-26	32	18	/	/	SYM
dhrp-26	32	19	biontech	biontech	NOUN
dhrp-26	32	20	vaccine	vaccine	NOUN
dhrp-26	32	21	.	.	PUNCT
dhrp-26	33	1	august	august	PROPN
dhrp-26	33	2	23	23	NUM
dhrp-26	33	3	,	,	PUNCT
dhrp-26	33	4	2021	2021	NUM
dhrp-26	33	5	.	.	PUNCT
dhrp-26	34	1	https://www.fda.gov/media/151710/download	https://www.fda.gov/media/151710/download	ADP
dhrp-26	34	2	4	4	NUM
dhrp-26	34	3	.	.	X
dhrp-26	34	4	us	us	PROPN
dhrp-26	34	5	food	food	NOUN
dhrp-26	34	6	and	and	CCONJ
dhrp-26	34	7	drug	drug	PROPN
dhrp-26	34	8	administration	administration	NOUN
dhrp-26	34	9	’s	’s	PART
dhrp-26	34	10	letter	letter	NOUN
dhrp-26	34	11	of	of	ADP
dhrp-26	34	12	emergency	emergency	NOUN
dhrp-26	34	13	use	use	NOUN
dhrp-26	34	14	authorization	authorization	NOUN
dhrp-26	34	15	for	for	ADP
dhrp-26	34	16	moderna	moderna	PROPN
dhrp-26	34	17	mrna	mrna	PROPN
dhrp-26	34	18	vaccine	vaccine	NOUN
dhrp-26	34	19	.	.	PUNCT
dhrp-26	35	1	december	december	PROPN
dhrp-26	35	2	18	18	NUM
dhrp-26	35	3	,	,	PUNCT
dhrp-26	35	4	2020	2020	NUM
dhrp-26	35	5	.	.	PUNCT
dhrp-26	36	1	https://immunize.utah.gov/wpcontent/uploads/2020/12/moderna_covid19_vaccine_eua_letter_of_authorization.pdf	https://immunize.utah.gov/wpcontent/uploads/2020/12/moderna_covid19_vaccine_eua_letter_of_authorization.pdf	PROPN
dhrp-26	36	2	sohail	sohail	PROPN
dhrp-26	36	3	rao	rao	PROPN
dhrp-26	36	4	,	,	PUNCT
dhrp-26	36	5	md	md	PROPN
dhrp-26	36	6	,	,	PUNCT
dhrp-26	36	7	ma	ma	PROPN
dhrp-26	36	8	,	,	PUNCT
dhrp-26	36	9	dphil	dphil	ADJ
dhrp-26	36	10	executive	executive	ADJ
dhrp-26	36	11	vice	vice	NOUN
dhrp-26	36	12	president	president	NOUN
dhrp-26	36	13	,	,	PUNCT
dhrp-26	36	14	dhr	dhr	PROPN
dhrp-26	36	15	health	health	PROPN
dhrp-26	36	16	,	,	PUNCT
dhrp-26	36	17	5501	5501	NUM
dhrp-26	36	18	s.	s.	PROPN
dhrp-26	36	19	mccoll	mccoll	PROPN
dhrp-26	36	20	road	road	PROPN
dhrp-26	36	21	,	,	PUNCT
dhrp-26	36	22	edinburg	edinburg	PROPN
dhrp-26	36	23	,	,	PUNCT
dhrp-26	36	24	texas	texas	PROPN
dhrp-26	36	25	president	president	PROPN
dhrp-26	36	26	&	&	CCONJ
dhrp-26	36	27	chief	chief	ADJ
dhrp-26	36	28	executive	executive	ADJ
dhrp-26	36	29	officer	officer	NOUN
dhrp-26	36	30	,	,	PUNCT
dhrp-26	36	31	dhr	dhr	PROPN
dhrp-26	36	32	health	health	PROPN
dhrp-26	36	33	institute	institute	PROPN
dhrp-26	36	34	for	for	ADP
dhrp-26	36	35	research	research	PROPN
dhrp-26	36	36	&	&	CCONJ
dhrp-26	36	37	development	development	PROPN
dhrp-26	36	38	,	,	PUNCT
dhrp-26	36	39	5323	5323	NUM
dhrp-26	36	40	s.	s.	PROPN
dhrp-26	36	41	mccoll	mccoll	PROPN
dhrp-26	36	42	road	road	PROPN
dhrp-26	36	43	,	,	PUNCT
dhrp-26	36	44	edinburg	edinburg	PROPN
dhrp-26	36	45	,	,	PUNCT
dhrp-26	36	46	texas	texas	PROPN
dhrp-26	36	47	corresponding	corresponding	PROPN
dhrp-26	36	48	author	author	NOUN
dhrp-26	36	49	email	email	NOUN
dhrp-26	36	50	:	:	PUNCT
dhrp-26	36	51	s.rao@dhr-rgv.com	s.rao@dhr-rgv.com	X
dhrp-26	36	52	disclosures	disclosure	NOUN
dhrp-26	36	53	:	:	PUNCT
dhrp-26	36	54	none	none	NOUN
dhrp-26	36	55	orcid	orcid	NOUN
dhrp-26	36	56	:	:	PUNCT
dhrp-26	36	57	sohail	sohail	PROPN
dhrp-26	36	58	rao	rao	PROPN
dhrp-26	36	59	:	:	PUNCT
dhrp-26	36	60	https://orcid.org/0000-0001-50279992	https://orcid.org/0000-0001-50279992	PROPN
dhrp-26	36	61	manish	manish	PROPN
dhrp-26	36	62	singh	singh	PROPN
dhrp-26	36	63	,	,	PUNCT
dhrp-26	36	64	md	md	PROPN
dhrp-26	36	65	,	,	PUNCT
dhrp-26	36	66	facs	facs	PROPN
dhrp-26	36	67	chief	chief	ADJ
dhrp-26	36	68	executive	executive	ADJ
dhrp-26	36	69	officer	officer	NOUN
dhrp-26	36	70	,	,	PUNCT
dhrp-26	36	71	dhr	dhr	PROPN
dhrp-26	36	72	health	health	PROPN
dhrp-26	36	73	,	,	PUNCT
dhrp-26	36	74	5501	5501	NUM
dhrp-26	36	75	s.	s.	PROPN
dhrp-26	36	76	mccoll	mccoll	PROPN
dhrp-26	36	77	road	road	PROPN
dhrp-26	36	78	,	,	PUNCT
dhrp-26	36	79	edinburg	edinburg	PROPN
dhrp-26	36	80	,	,	PUNCT
dhrp-26	36	81	texas	texas	PROPN
dhrp-26	36	82	disclosures	disclosure	NOUN
dhrp-26	36	83	:	:	PUNCT
dhrp-26	36	84	none	none	NOUN
dhrp-26	36	85	orcid	orcid	NOUN
dhrp-26	36	86	:	:	PUNCT
dhrp-26	37	1	manish	manish	PROPN
dhrp-26	37	2	singh	singh	PROPN
dhrp-26	37	3	:	:	PUNCT
dhrp-26	37	4	https://orcid.org/0000-00034146-3282	https://orcid.org/0000-00034146-3282	PROPN
dhrp-26	37	5	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	PROPN
dhrp-26	37	6	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	PROPN
dhrp-26	37	7	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	PROPN
dhrp-26	37	8	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	https://nps.edu/documents/111291366/124403968/pfizer-biontech+covid-19+vaccine+eua+loa+%2811+dec+2020%29.pdf/106e9662-956c-aa94-8d4b-a945a6a10b87?t=1608071313236	PROPN
dhrp-26	37	9	https://www.fda.gov/media/144412/download	https://www.fda.gov/media/144412/download	PRON
dhrp-26	37	10	https://www.fda.gov/media/151710/download	https://www.fda.gov/media/151710/download	ADP
dhrp-26	37	11	https://immunize.utah.gov/wp-content/uploads/2020/12/moderna_covid-19_vaccine_eua_letter_of_authorization.pdf	https://immunize.utah.gov/wp-content/uploads/2020/12/moderna_covid-19_vaccine_eua_letter_of_authorization.pdf	PROPN
dhrp-26	37	12	https://immunize.utah.gov/wp-content/uploads/2020/12/moderna_covid-19_vaccine_eua_letter_of_authorization.pdf	https://immunize.utah.gov/wp-content/uploads/2020/12/moderna_covid-19_vaccine_eua_letter_of_authorization.pdf	PROPN
dhrp-26	37	13	https://immunize.utah.gov/wp-content/uploads/2020/12/moderna_covid-19_vaccine_eua_letter_of_authorization.pdf	https://immunize.utah.gov/wp-content/uploads/2020/12/moderna_covid-19_vaccine_eua_letter_of_authorization.pdf	PROPN
dhrp-26	37	14	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-26	37	15	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-26	37	16	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN
dhrp-26	37	17	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN